| Literature DB >> 34158001 |
Miao Wu1,2, Xiaoxia Shen3, Can Lai4, Weihao Zheng5, Yingqun Li4, Zhongli Shangguan4, Chuanbo Yan6, Tingting Liu5, Dan Wu5.
Abstract
BACKGROUND: Neonatal hyperbilirubinemia is a common clinical condition that requires medical attention in newborns, which may develop into acute bilirubin encephalopathy with a significant risk of long-term neurological deficits. The current clinical challenge lies in the separation of acute bilirubin encephalopathy and non-acute bilirubin encephalopathy neonates both with hyperbilirubinemia condition since both of them demonstrated similar T1 hyperintensity and lead to difficulties in clinical diagnosis based on the conventional radiological reading. This study aims to investigate the utility of T1-weighted MRI images for differentiating acute bilirubin encephalopathy and non-acute bilirubin encephalopathy neonates with hyperbilirubinemia.Entities:
Keywords: Acute bilirubin encephalopathy; Classification; Deep convolutional neural networks; Diagnosis; Hyperbilirubinemia; Normalized T1-weighted intensities; ResNet18
Mesh:
Year: 2021 PMID: 34158001 PMCID: PMC8218479 DOI: 10.1186/s12880-021-00634-z
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 1.930
Fig. 1ROI of the image and distribution map of patients’ GP norm and STN norm. a ROI definitions. Green: white matter, red: globus pallidus, blue: subthalamic nucleus. GPnorm (b) and STNnorm (c) in the ABE and non-ABE HB patients
Fig. 2a The basic residual block. b The ResNet18 architecture. The numbers in each convolutional layers denote the number of filters
The demographic and clinical characteristics of the HB patients used in this study
| Clinical features | ABE positive (n = 47) | ABE negative (HB) (n = 32) | |
|---|---|---|---|
| Sex (male) | 29(61.70%) | 23(71.88%) | 0.349 |
| Age (days) | 9.83 ± 3.05 | 12.15 ± 5.28 | 0.032 |
| Weight (kg) | 3.21 ± 0.48 | 3.36 ± 0.43 | 0.162 |
| Gestational age (weeks) | 38.47 ± 1.58 | 38.38 ± 1.47 | 0.792 |
| TSB (μmol/L) | 369.11 ± 114.78 | 326.13 ± 79.20 | 0.070 |
| Albumin (g/L) | 38.34 ± 2.98 | 38.45 ± 3.21 | 0.873 |
Fig. 3Representative T1WI from three ABE and three non-ABE neonates who were diagnosed as HB. The arrows pointed to the bilateral areas of the globus pallidus
The classification performance of visual inspection, GPnorm, and ResNet18 in separating ABE from non-ABE HB patients, as evaluated by sensitivity, specificity, precision, F1-score, Accuracy, AUC
| Methods | Sensitivity | Specificity | Precision | F1-Score | Accuracy | AUC |
|---|---|---|---|---|---|---|
| Visual inspection | 52.48 ± 13.58% | 55.21 ± 7.86% | 62.95 ± 3.58% | 56.79 ± 8.90% | 53.58 ± 5.71% | 53.87 ± 4.11% |
| GPnorm | 68.10% | |||||
| ResNet18 | 45.26 ± 19.19% | 59.58 ± 7.09% | 67.11 ± 8.28% | 62.11 ± 8.03% | 68.92 ± 11.06% |
The maximum value of performance metrics for each method was marked in bold
Fig. 4Confusion matrices and ROC curves of classification results of three different methods. a Confusion matrix based on the radiological inspection. b Confusion matrix based on ResNet18. c Confusion matrix based on semi-quantitative measurement of GPnorm. d ROC curves for three different methods. The corresponding AUC values were denoted in the lower right corner
Fig. 5a A training progress of ResNet18 in fivefold cross-validation: the accuracy and loss history. b Class activation map of resnet18 for 4 exemplary test samples. The colormap showed the contribution of the voxels in the network in predicting results and the red region contribute most
Fig. 6Examples of false-positive cases (non-ABE HB patients who were misclassified as ABE) and false-negative cases (ABE patients who were misclassified as non-ABE HB) by the ResNet18 network